Researcher develops microrobots to battle cancer with unique precision

May 1, 2024

4 min

Sambeeta Das


Magnetic robots that can target cancer cells are nothing new. But the patented microrobots developed by the University of Delaware's Sambeeta Das can be guided with a magnetic field to deliver medication to cells – or to destroy infectious cells, such as cancer – inside the body.


To mark the launch of National Inventors Month, Das, assistant professor of mechanical engineering, shared her journey toward invention.


Q: Tell us about your patented invention on microrobots for cancer research. What problem were you trying to solve?


Das: One of the biggest issues with cancer research is the ability to target cancer cells without harming healthy cells. Cancer cells are sneaky, and they have evolved ways of hiding from the body’s immune cells.


A big part of our research focuses on targeting, specifically precision targeting. We want to be able to target a single cell in a mass of cells, whether that is a single cell in a mass of cancer cells or whether it is a single abnormal cell surrounded by healthy cells. To do this, we use magnetic microrobots that can be driven inside the body by magnetic fields to a particular cell location. Magnetic fields are biocompatible, meaning they are not harmful to biological tissues, and our microrobots are very small, around 20 microns, which is about the size of a single bacteria cell. We can load our microrobots with various drugs and modify their surface in such a way that when the robots come in contact with the cells we are targeting, they can kill the target cell or perform some other function.


Q: How is this solution unique?


Das: Other people have made magnetic microrobots, but our system is unique since it allows us to do automatic targeting with a lot of precision. For example, a person operating our microrobots can just point to a cell and our system will drive the microrobot there. Additionally, the instrument we have made and patented is an all-in-one portable device that can be used anywhere. We don’t need a separate microscope, camera or software, it is all built in and very user friendly. Anyone can use it. This makes it super portable, which means quick solutions for health practitioners. In addition, poor and resource challenged areas can also be accessed with this portable solution.

Q: What drives you toward invention?


Das: I like to solve problems, and I like seeing something come together from nothing. I am very interested in problems that affect human health and longevity, particularly those that affect the common person.


Q: How do you approach solving a problem, and whose support has been critical along the way?


Das: One thing I have realized is that it is imperative to ask the right question to solve a problem. You must really get to the core of the issue. The second thing is to always keep the end user in mind. So, it’s kind of a two-pronged approach—looking from both ends of the problem.


For support, I would say my team members and my collaborators. Their support has been invaluable in helping me solve the problems that I want to solve. In fact, my graduate students keep a running list of crazy ideas that they have come up with. It helps us look at problems in a unique way and come up with innovative solutions.


Q: Not every invention makes it. How do you deal with failure?


Das: The way that I start working on a problem is to assume that whatever we do, we are going to fail. I always tell my students that their first couple of experiments or designs will always fail. But failure is essential because it will teach you what not to do. And knowing what not to do is sometimes the critical part of the invention process. The failures inform us about the ways of not doing something which means now there is another way of doing something.


Q: What is the best advice you’ve ever received?


Das: The best career advice I’ve ever received is that there is always another way. If you run into roadblocks there is always another answer, there is always another opportunity. So we just need to keep going and trying new and crazy ideas.


Q: How are inventive minds created – is it innate or can it be developed? How do you encourage innovation among your students?


Das: That’s an interesting question and honestly, I am not sure. I do believe in what Edison said, “Genius is 1% inspiration and 99% perspiration.” He is a known inventor, so I would go with his interpretation on this.


As for my students, I give them lots of freedom. I think freedom is essential in encouraging innovation. The freedom to come up with crazy ideas without anyone saying that won't work and the freedom to fail—multiple times.


Das is available for interviews to talk about her microrobots and other projects at UD. To reach her, visit her profile and click the "contact" button.

Connect with:
Sambeeta Das

Sambeeta Das

Assistant Professor of Mechanical Engineering

Prof. Das’s research spans robotics, autonomous systems, physics, organic chemistry and materials engineering.

Biomechanical EngineeringClean Energy & EnvironmentMaterials EngineeringBiomechanicsFluid Mechanics
Powered by

You might also like...

Check out some other posts from University of Delaware

2 min

The science behind the blood moon: Understanding this lunar phenomenon ahead of march's event

March's celestial event – a blood moon – is just around the corner. This captivating lunar spectacle isn't just a cool sight to behold; it has some neat science backing it up. The blood moon phenomenon happens during a total lunar eclipse. "During a total lunar eclipse, the only light that reaches the surface of the moon is refracted through the Earth's atmosphere, which essentially acts like a lens. Light is a wave, and every color of the rainbow has a different wavelength – red the longest and violet the shortest," said Bennett Maruca, associate professor of physics and astronomy at the University of Delaware.  What adds to the excitement is the rare nature of total lunar eclipses. While partial eclipses occur more frequently, a full blood moon isn't an everyday event. Depending on where you live, the blood moon may only grace the night skies a few times a decade. "One of my favorite things about total lunar eclipses is that it's hard to know ahead of time quite what it will look like. The moon can take on a color ranging from burnt orange to red to grayish brown," he said. "The closer the Moon passes to the center of Earth's shadow, the darker the color will be."  Maruca is available to speak about the event, which takes place in the wee hours of March 3. He can discuss when to wake up to see the phenomenon and how to best capture it.  "For photographing the moon, I would recommend a camera with some optical zoom – the moon is only about 0.5 degrees across. Because of the low lighting conditions, a tripod or other support would be helpful since a longer exposure time will be needed," he noted.  He has appeared in a number of outlets including Mashable and The Philadelphia Inquirer. He can be contacted by clicking on his profile.  ABOUT BENNET MARUCA Bennett Maruca serves as an associate professor in the University of Delaware's department of physics and astronomy. His research focuses on the sun, the solar wind and other space plasmas. He is a recipient of the Antarctic Service Medal and NASA's Silver Achievement Medal. He also serves as an associate director of the Delaware Space Grant Consortium and is currently mentoring over twenty undergraduate students developing experiments to fly into space to observe Earth's ionosphere.

2 min

Solving for X: Expert highlights importance of algebra in middle and high school

Math educators agree that Algebra is a critical course for middle and high schoolers, often serving as a gateway to more advanced math courses and influencing students’ academic trajectories in STEM pathways. Yet, many students struggle in this important course. Since May 2025, University of Delaware Associate Professor Erica Litke has partnered with the University of Pennsylvania Graduate School of Education and the School District of Philadelphia in a $5 million, three-year initiative to improve algebra teaching in the district. The project offers algebra teachers professional development through a year-long fellowship. With expertise in improving instructional quality in math and supporting algebra teaching, Litke leads the design and delivery of the professional development with Penn GSE experts. Close to 80 teachers participated in the first cohort of the fellowship, which includes a four-day summer institute. Litke’s research in math education has connected instructional quality to broader policy issues in education and focused on teacher knowledge and professional development. “The focus on algebra content and key features of algebra teaching that support students in learning algebra content helps teachers translate their learning from the fellowship directly into their teaching practice,” said Litke. “Being able to translate my research findings into usable knowledge for teachers and contribute to the design of this kind of comprehensive professional learning has been really exciting.” Litke can speak to her role in the Algebra Fellowship project, the importance of Algebra 1 in the trajectory of students’ STEM education and strategies for supporting teaching learning at the school and district levels. ABOUT ERICA LITKE Erica Litke is an associate professor specializing in mathematics education in the School of Education at the University of Delaware. Her research focuses on understanding and improving instructional quality in mathematics for students in the elementary and secondary grades. Her research has described and analyzed instructional practice in mathematics using observation instruments, connected instructional quality in mathematics to broader policy-related issues in education, and focused on teacher knowledge and professional development. She has appeared in The Philadelphia Inquirer, Daily Pennsylvanian and other publications. To speak with Litke or to learn more, email mediarelations@udel.edu.

2 min

Discovery pinpoints potential Achilles’ Heel in HIV, opening new frontier in drug development

Scientists have long known that detecting HIV early is crucial in slowing and treating the virus. During the acute stage of infection, a single human cell can produce as many as 10,000 new HIV particles. A discovery led by the University of Delaware's Juan Perilla offers hope: A new drug target early in the virus's life cycle that could save millions of lives. In the surprising discovery, published Feb. 18 in Nature, Perilla and collaborators in the U.S. and the United Kingdom, have revealed a previously unknown role for the viral protein integrase. Scientists already knew that integrase helps HIV insert itself into human DNA. But this new study provides the first direct evidence that integrase plays a critical structural role earlier on in HIV’s life cycle — when the virus matures into an infectious force. Using high-resolution cryo-electron microscopy (cryo-EM), the research team – which also included UD doctoral student Juan S. Rey – found that integrase proteins form gluey filaments that line the inside of the capsid. Each segment of the filament slots neatly into the capsid’s hexagon-shaped tiles, while gripping tightly to HIV’s RNA genome. This zipper-like arrangement organizes and packs the virus, preparing it to hijack a cell and start making copies of itself. “Integrase plays a structural role inside the HIV capsid — nobody expected that,” Perilla said. “This protein forms filaments that anchor the RNA to the capsid. Without these filaments, the virus is non-infective.” Seeing inside HIV is no small feat. The capsid is only about 120 nanometers wide —roughly 1/800th the thickness of a human hair. It is incredibly small, fragile, densely packed and constantly changing, Perilla said. To reveal its hidden architecture, the researchers relied on deep collaboration and a combination of sophisticated microscopy, molecular modeling and experimentation. Read more about the science behind the study here. “The thing with HIV is that people are chronically living with it,” Perilla said. “Treatments are effective, but patients always need new therapeutics. We want to help develop the next generation of inhibitors and hope to have a significant contribution.” To reach Perilla directly and arrange an interview, visit his profile page. Interested reporters can also email MediaRelations@udel.edu.

View all posts